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Background: Studies have consistently shown that copper alloyed surfaces decrease the burden of mi-
croorganisms in health care environments. This study assessed whether copper alloy surfaces decreased
hospital-associated infections in pediatric intensive and intermediate care units.
Methods: Admitted infants were assigned sequentially to a room furnished with or without a limited
number of copper alloyed surfaces. Clinical and exposure to intervention data were collected on a daily
basis. To avoid counting infections present prior to admission, patients who stayed in the hospital <72
hours were excluded from analysis. Health care–associated infections (HAIs) were conﬁrmed according
to protocol deﬁnitions.
Results: Clinical outcomes from 515 patients were considered in our analysis: 261 patients from the in-
tervention arm of the study, and 254 from the control arm. Crude analysis showed an HAI rate of 10.6
versus 13.0 per 1,000 patient days for copper- and non–copper-exposed patients, respectively, for a crude
relative risk reduction (RRR) of 0.19 (90% conﬁdence interval, 0.46 to -0.22). Conducting clinical trials to
assess interventions that may impact HAI rates is very challenging. The results here contribute to our
understanding and ability to estimate the effect size that copper alloy surfaces have on HAI acquisition.
Conclusions: Exposure of pediatric patients to copper-surfaced objects in the closed environment of the
intensive care unit resulted in decreased HAI rates when compared with noncopper exposure; however,
the RRR was not statistically signiﬁcant. The clinical effect size warrants further consideration of this in-
tervention as a component of a systems-based approach to control HAIs.
© 2016 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and
Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Health care–associated infections (HAIs) are amajor public health
concern causing signiﬁcant morbidity and mortality that could be,
to some ﬁnite extent, prevented. Progress in reducing HAIs has been
achieved through the implementation of low technology and low-
cost interventions, such as hand hygiene and disinfection of the
environment. However, the full eﬃcacy that each approach offers
has not been fully realized for many different reasons.1
Handwashing is considered the single most effective interven-
tion for controlling infection; however, compliance rates continue
to be an issue.2 Environmental cleaning and disinfection have been
overlooked since Spaulding3 categorized noncritical items as less
important in the chain of events leading to infection. Asepsis and
antiseptics have completely changed the landscape such that we
need to target new reservoirs, newmechanisms of transmission, and
new microorganisms. Recently, strong evidence has been gener-
ated suggesting that near-patient high-touch surfaces may act as
important reservoirs for some hospital pathogens causing HAIs.4,5
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In controlled in vitro experiments, and during the conduct of
pragmatic clinical trials, copper alloys have consistently displayed
a profound and persistent antimicrobial activity.6-8 Salgado et al9
evaluated the antimicrobial activity of copper in the context of
whether or not lower microbial burdens proximal to the patient
would result in lower acquisition rates of HAI and learned that
through the reduction in microbial burden on selected surfaces and
components in the rooms of patients, a subsequent and signiﬁ-
cant reduction of HAI rates was observed. However, the study was
conducted in adult medical intensive care units, and therefore it
remains to be seen how the reduced bacterial burden might impact
the HAI rates in different clinical settings and in different patient
populations.
The methodologic challenges for estimating a signiﬁcant reduc-
tion in HAI rates, as inﬂuenced by copper surfaces in different clinical
settings, are manifold. First, a randomized controlled trial (RCT)
seems to be the ideal design but presents the following chal-
lenges: (1) masking the intervention is challenging; (2)
randomization is complicated because the intervention does not act
at the level of the individual but rather on the microbes proxi-
mate to the care being provided; and (3) for busy critical health care
units it may not be feasible to randomly assign patients to a par-
ticular room based on their medical need. Further, the very deﬁnition
of the primary outcome required from such studies, acquisition of
an HAI, is problematic because although ideal and detailed deﬁni-
tions of HAIs suited for epidemiologic purposes exist, their utility
is limited as a consequence because they are not easily abstracted
from medical records with the level of precision expected from a
binary outcome. HAI deﬁnitions can also vary according to the pop-
ulation involved (eg, bloodstream infections associated with
immunocompromised vs immunocompetent patients), from country
to country, and from many other perspectives.10
In the work from Salgado et al,9 they reported results of an RCT
aimed at estimating the effect of copper-surfaced objects on HAI
and colonization rates in adult patients admitted to the intensive
care units of 3 hospitals in the United States. They found that the
limited introduction of 6 copper components resulted in a statis-
tically signiﬁcant reduction of HAI rates and methicillin-resistant
Staphylococcus aureus or vancomycin-resistant Enterococcus colo-
nization in the intervention arm of the study compared with the
control arm. The observed HAI incidence rates were 0.071 and 0.123
for the intervention and control groups, respectively, with a rela-
tive reduction risk (RRR) of 0.42. These promising results encouraged
us to run a similar trial with respect to the number of copper com-
ponents introduced as an additional component of a comprehensive
infection control strategy in a different setting to compare esti-
mates of the intervention effect. Our trial objectives were 2-fold.
The ﬁrst, for which results were recently published,11 compared the
microbial burden alleviated by the intervention (the limited intro-
duction of copper components) with themicrobial burden associated
with the control surfaces. The second, addressed here, was to
measure the clinical impact that copper alloy surfaces had on the
HAI acquisition rates seen in 2 pediatric intensive care settings.
METHODS
Study design and setting
This study was conducted using a nonrandomized, unmasked,
controlled clinical trial. The protocol was registered before the ini-
tiation of the study (ClinicalTrials.gov identiﬁer no. NCT01678612).
Although the study design was not ideal, it was deemed meritori-
ous and was conducted under the umbrella of a pragmatic trial.12,13
The study was conducted in the pediatric intensive care unit
(PICU) and intermediate pediatric care unit (PIMCU) of the Roberto
del Rio Hospital, Santiago, Chile, which is a 249-bed tertiary hos-
pital. Recruitment lasted 12 months. Eligible participants were all
patients admitted to the study site. Although wewould analyze only
patients staying >3 days in the ward, we included all patients in the
study because we could not judge beforehand the length of the
patient’s stay. The only exclusion criterion was lack of informed
consent. The PICU has 6 two-bed rooms and 2 single-bed rooms.
The PIMCU has 1 four-bed rooms, 5 three-bed rooms, and 2 single-
bed rooms.
Intervention
Half of the rooms (n = 8) were furnished with copper-surfaced
items, and the other half remained unchanged. Intervened rooms
were located in the space in an alternate fashion.10 The selected items
surfaced with copper were bed rails, bed rail levers, intravenous
poles, sink handles, and the nurses’ workstation. Handwashing pro-
cedures and cleaning routines remained the same before and
throughout the study period. The hand hygiene compliance rate of
health care workers was assessed by staff not aﬃliated with the trial
and was reported quarterly as a measure of health care worker ad-
herence to the established protocol for hand hygiene before and after
patient contact. For the period of the trial, the mean compliance
rate for the health care workers observed in the units (N = 153), ex-
pressed as the percentage of individuals that complied entirely with
the hospital standards for intensive care unit wards, was 93% (range,
80%-100%).
Assignment to experimental arm
On admission, to each unit, patients were sequentially as-
signed to either an intervened or control room. Swapping patients
from one unit to the other was discouraged but was allowed for com-
pelling medical reasons; however, the protocol stated that patients
should move to the same type of room (intervened or control) as
originally assigned.
Ethics and regulatory requirements
Written informed consent was obtained from each parent or legal
guardian within 24 hours of admission. This study was conducted
in accordance with the Helsinki Declaration, the International Con-
ference on Harmonization Guidance for Good Clinical Practice, and
applicable national regulations. The study protocols and informed
consent formwere approved by the research ethics committee over-
seeing clinical research at the local site.
Measurements
Demographic and clinical data were collected at entry for all el-
igible patients. Thereafter, clinical data regarding installation and
removal of invasive catheters (central venous catheters, indwell-
ing urinary catheters, and tracheal intubation for mechanical
ventilation), instauration of antimicrobial therapy, room location,
and HAI suspicion status were collected on a daily basis until patient
discharge from the unit. An inventory log was designed to keep track
of the presence or removal of items with and without copper sur-
faces from their original assigned room.
Bacterial burden was measured on selected surfaces (bed rails,
cribs, and faucet handles) from both groups on a bimonthly basis
during study duration. Detailed results of this aim of the study are
reported elsewhere.11
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Outcome
The primary outcome of the study was the diagnosis of an HAI
event associated with patient stay within the PICU or PIMCU. Ac-
cording to broadly accepted criteria, signs and symptoms should
appear on or after the third calendar day of admission to the facility.14
HAI deﬁnitions used were the standard deﬁnitions used by the Na-
tional Surveillance System of the Ministry of Health of Chile.15
However, to evaluate the reliability of the results, an independent
review of the source documents was conducted on a subset of the
study subjects (122/515; 24% records) on completion of the study.
The reviewer was blinded to the assignment of the patient to the
intervention or control group and to the occurrence or not of an
acquisition of an HAI, the primary outcome.
Safety
Although the anticipated risk of harm associated with the study
was very low, possible skin or other allergic reactions to either the
patients or hospital staff were monitored during the study. Mor-
tality data were also collected.
Statistical methodology
Sample size was estimated on the basis of available local data.
An expected HAI incidence rate of 14.4 per 1,000 patient days for
the control group was derived from ﬁgures from the study wards
reported to the HAI National Surveillance System along with a short
retrospective study of administrative data from the previous year.
The historical number of patients admitted annually to the local site
was approximately 1,100, resulting in an expected number of 7,500
patient days for the study duration. Allowing for a 10% dropout from
the analysis, we estimated that approximately 3,400 patient days
would be required per group to yield an approximate 85% statis-
tical power to show a 50% reduction of the HAI rate in the
intervention group compared with the control group, with a 2-sided
type I error of 0.05 within the 12 months allotted for the trial. The
analysis was planned on an intention-to-treat basis because some
protocol deviations regarding actual exposition to copper (objects
removed or displaced) were expected. Considering that repeated
infections on the same patient are not independent events, the anal-
ysis counted solely the ﬁrst HAI observed on each patient. A κ statistic
was derived to assess agreement between original HAI determina-
tions and those for the validated subsample. A Poisson regression
model was planned to control for selected variables according to
clinical considerations. R package version 3.2.2 (R Foundation for
Statistical Computing, Vienna, Austria) was used for statistical
analyses.
RESULTS
Study population
A total of 1,012 patients were admitted to the PICU-PIMCU during
the 12 months of study duration (November 12, 2012-November
15, 2013). To avoid counting possible infections present prior to ad-
mission, patients who stayed in the hospital <72 hours were excluded
from analysis. The distribution of patients within each arm of the
study and unit of admission is shown in Figure 1. Demographic and
relevant clinical features of enrolled patients are described in Table 1.
In spite of patients not being randomizedwhen allocated to the study
group, fair balance between baseline characteristics was ob-
served. In particular, regarding aspects that increase the likelihood
of developing an HAI, for example, speciﬁc pre-existing condi-
tions and the number of patients with invasive medical catheters
and time of exposure to invasive medical devices.
Setting considerations and adherence with study protocol
The mean bed occupancy rate during the study period was 70%
(monthly range, 14%-121%) for the PICU and 43% (monthly range,
12%-94%) for the PIMCU. In the PICU, during July and August, the
bed occupancy rate was >100% (22 and 14 days, respectively, or 85%
of the time). This meant that, in the best interest of the patients,
additional noncopper beds were placed in some intervened rooms
of the PICU. Moreover, during the same winter months, some pa-
tients allocated to copper-surfaced beds were moved to noncopper
rooms, representing an estimated deviation of the protocol of 12%
over the corresponding 868 patient days of the busiest winter
months. Shortly after the initiation of the trial, it became appar-
ent that the patients from the 4-bed room of the PIMCU (control
arm room) should be excluded from the trial because they were clas-
siﬁed as long-term or chronic patients. The patients associated with
this room were excluded from subsequent analyses because their
inclusion would skew the overall study occupancy rate and patient
demographics.
Analysis of primary outcome
Overall, 65 patients developed 91 medical conditions compat-
ible with the protocol deﬁnition of an HAI, 32 patients were from
the intervention group and 33 from the control group, resulting in
an HAI incidence rate of 10.6 and 13.0 per 1,000 patient days, re-
spectively, which corresponds to an 0.19 RRR of HAI for patients
exposed to copper-surfaced objects compared with control pa-
tients. In addition, as prescribed in the study protocol, a Poisson
regression model was ﬁtted to control for selected variables ac-
cording to clinical considerations. The offset parameter was the log
of the number of patient days in each group (intervention and
control). Two variables (ie, number of days with invasive cath-
eters [indwelling urinary catheter, central venous catheter, and
endotracheal intubation], age) were the covariates that best ﬁt the
1,012 subjects 
admited during 
conduct of trial
506
subjects admitted to 
intervened room
261
 exposed to 
intervention
245 excluded from 
analysis ( < 72 hours 
length of stay)
478 
subjects admitted to 
control room
254
 not exposed 
to intervention
224 excluded from 
analysis (< 72 hours 
length of stay)
28 parents /legal guardians 
refused or were unable to 
consent
Fig 1. Flow diagram of patient data used for analysis. There were 1,012 patients avail-
able for consent for subsequent enrollment during the trial periodwithin the pediatric
intensive care unit and intermediate pediatric care unit of the Hospital Roberto del
Rio, Santiago Chile.
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model. The adjusted estimate of the effect provided by the incor-
poration of copper into the built clinical environment from the ﬁtted
model was an RRR of 0.26 (90% conﬁdence interval, 0.48 to -0.06)
(Table 2).
Forty-two patients developed only 1 HAI during the study period,
21 developed 2 HAIs, 1 developed 3 HAIs, and 1 developed 4 HAIs.
Only the ﬁrst HAI event was considered in the primary analysis.
Urinary tract infection (UTI) and bloodstream infections were the
most common types of HAI. Patients who developed HAI events in
the intervened arm of the study had pre-existing conditions more
frequently than patients in the control group and had longer lengths
of stay (Table 2).
The data associated with Table 3 illustrate the type of infection
and the pathogens isolated among HAI cases encountered in the
room containing copper components and control rooms. Three pa-
tients displaying the symptoms of pneumonia were diagnosed solely
using clinical criteria because all samples cultured were negative.
This is a commonly observed occurrence with cases of suspected
pneumonia. All 3 corresponded to patients assigned to the inter-
vention arm of the study. A clear imbalance is observed in the
number of UTI cases being more frequent in patients assigned to
the control arm.
Independent review of source documents
An independent expert (blinded to the experimental assign-
ment) reviewed the medical records, nurse charts, and laboratory
results of 122 patients. Fifty four were HAI cases, and 68 were
matched non-HAI cases. Matching parameters were length of stay,
sex, and unit of admission. Each patient was classiﬁed as case or
noncase according to an algorithm (previously established by the
expert), which included number of days with fever, polymerase chain
reaction levels, source of cultures, type of microorganisms iso-
lated, and so forth. A test for agreement (κ score) gave an estimate
of 0.41, which can be considered moderate agreement.
Secondary analyses
The potential inﬂuence of bed occupancy over time on the oc-
currence of cases was explored. Excess occupancy rates (>100%) were
only observed in the PICU; therefore, we analyzed PICU alone in a
subgroup unplanned analysis. Figure 2 summarizes the distribu-
tion of HAI occurrence, bed occupancy rates, and surface bacterial
burden measured over the study period. Median bacterial burden
in the control rooms ﬂuctuated at high levels, somewhat follow-
ing occupancy rates within the PICUward, whereas median bacterial
burden in intervened rooms stayed steadily low. Although HAI cases
in the intervention group seem to occur more or less randomly over
time, HAI cases in the control group show a clustering trend during
July-August (7 and 14 cases for the copper and noncopper group,
respectively), coinciding with an isolated increase of median bac-
Table 1
Demographic and clinical characteristics at study entry & postadmission characteristics
Characteristic Intervention Control P value
Patients consented PICU and PIMCU, n 261 254
Patients treated in PICU, n (%) 130 (50) 149 (59) .05
Sex (male), n (%) 141 (54) 146 (58) .48
Age, n (%)
≤ 1 y 133 (51) 144 (57) .22
> 1 y 128 (49) 110 (43)
Median age (y) 1 1
Age range (y) 0-16 0-17
Pre-existing conditions
None 67 79 .46
Oncology-immunodeﬁciency 11 6
Gastrointestinal ostomy 8 7
Cardiovascular malformation 5 5
Other 9 5
Absence of devices at admission, % 83% 85% .55
Active antimicrobial therapy at
admission, %
17 13 .18
Frequent causes of admission, %*
Respiratory 57 60 .16
Infectious 49 52
General surgery recovery 12 6
Neurologic/neurosurgery 10/7 10/6
Trauma/burn 5/3 2/3
Sepsis: shock/oncology 5/6 9/4
Post admission characteristics
LOS
Median LOS, d 4 4
Range LOS, d 1-100 1-91
Patients with IUCs 150 128
Total days IUC 680 640
No. of patients with CVCs 144 133
Total days CVC 1,087 1,131
No. of patients with ETT 158 130
Total days ETT 731 729
CVC, central venous catheter; ETT, endotracheal intubation; IUC, indwelling urinary
catheter; LOS, length of stay.
*Sum of the percent may be >100% because each patient may have >1 pre-existing
condition at the time of admission.
Table 2
Primary end point: hospital-associated infection density rates
Primary endpoint Intervention Control
Relative risk
reduction (90% CI)
Total HAI cases 32 33
HAI by care unit, PICU/PIMCU 26/6 28/5
Patient days 3,012 2,531
Incidence rate, no. of HAIs per 1,000 patient days 10.6 13.0 0.81 (0.50-1.32)
Presence of pre-existing condition at time of HAI acquisition
Yes 15 6
No 17 27
Median length of stay, d 22 12
Range 3-158 4-96
No. of HAI cases 43 48
Bloodstream infection 15* 11
Urinary tract infection 9 16
Pneumonia 7† 4†
Surgical site infection 1† 2†
CI, conﬁdence interval; HAI, health care–associated infection; PICU, pediatric intensive care unit; PIMCU, intermediate pediatric care unit.
*One case without microbiologic conﬁrmation.
†Three cases without microbiologic conﬁrmation.
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terial burden on intervened rooms and also with occupancy rates
>100%.
Safety analysis
Adverse effects were not observed among the health care workers
or patients exposed to copper-surfaced items. There was no indi-
cation of excess mortality identiﬁed during the study. Eight patients
died during their course of care in the copper arm of the study,
whereas 9 patients died during the course of care in the control arm
of the study, accounting for an overall mortality rate of 2%.
DISCUSSION
In this pragmatic clinical trial, an intervention consisting of
placing selected copper alloy surfaced components in the environ-
ment in close proximity to patients admitted to the PICU and PIMCU
showed a moderate 19% (crude) to 26% (adjusted) reduction of in-
cident HAI rates compared with the control arm of the study.
Although not statistically signiﬁcant, the reduction to the HAI ac-
quisition rate in the copper arm suggests that the reductions to the
proximate environmental microbial burden near the patient warrant
further investigation. This study represents only the second such
RCT investigating a relationship between the environmental mi-
crobial burden and HAI acquisition. Here a pediatric population was
used to investigate this relationship. The copper components were
found to be equivalently effective in their ability to control the prox-
imate microbial burden to those used in the adult trial.9,11
Although the comparison between the 2 groups failed to achieve
signiﬁcance, we recall the advice offered by Altman and Bland who
encourage, “just because results are non-signiﬁcant does not nec-
essarily follow that the study found nothing of clinical importance.”16
Although the RRR observed in our study was lower than expected,
we offer that the actual overall effect that the lowered proximate
microbial burden (copper arm of the study) contributed to the HAI
acquisition rate in the pediatric units was somewhere between our
estimate and the one observed in the published adult intensive care
unit trial.9 Given that HAI acquisition is a complex and multifacto-
rial clinical phenomenon, here the fractional difference observed
between the copper intervention and control groupsmay not exceed
the proportion of HAIs facilitated by exogenous cross transmis-
sion. Harbarth et al concluded from their work that such cross
contamination for HAI acquisition may vary between 16% and 35%.17
Therefore, under this hypothesis, an extremely eﬃcacious environ-
mental intervention would, at the best, reduce HAI incidence by no
more than 30%.
Additionally, protocol deviations were encountered during the
course of our study during the winter season. Overcrowding led to
misplaced objects and the addition of extra beds and patients into
2 rooms of the PICU. This may have limited the antimicrobial con-
tribution provided by the copper intervention.
Some of our assumptions regarding statistical power calcula-
tions were not met. As already described, in the absence of better
information, our estimated copper effect was optimistic. Also, the
number of patients who failed to meet the minimum length of stay
(72 hours) in the unit was underestimated (expected: 10%, ob-
served: 47%). On a positive note, the estimated HAI incidence rate
for the control arm for our facility was in close agreement to our
estimate. In accordance with the published literature on the expo-
sure of human skin to metallic copper materials, no adverse events
were reported in association with the intervention. Similarly, mor-
tality rates were equivalent for both arms of the study.
In summary, and following recommendations on how to report
RCT results from pragmatic trials,18 we conclude that our results are
compatible (90% conﬁdence interval) with a 46% decrease or a 22%
increase of HAI rates. However, taking into account that there is no
biologic plausibility that lower microbial burdens should lead to in-
creases to HAI rates, and that a previous study showed a 42% decrease
to the HAI acquisition rate, we offer that copper-surfaced objects
offer a potential beneﬁt that needs to be determined with a greater
level of precision. Further, not all types of HAIs are likely to be equally
inﬂuenced by environmental interventions. The results here suggest
that there exists a greater effect on incidence rates for pediatric UTIs
(3 × 1,000 vs 6 × 1,000 patient days for copper and control groups,
respectively). Ideally, a target difference could be deﬁned, as pro-
posed by various methodologists and trialists.19
Despite the nonrandomized design of the study, both groups
looked fairly comparable from the perspective of the most fre-
quent clinical characteristics likely to introduce bias of some concern.
The nonblinded characteristic of the study design was a major
concern because, as previously stated, the diagnosis of HAI is a
complex process requiring clinical judgment, particularly when a
binary end point is lacking (ie, pathogen-positive culture). In this
study, the clinicians responsible for assessing the primary outcome
did not have access to the study database; therefore, they rapidly
lost track of partial results. Controversial end points were adjudi-
cated through a collective discussion among the medical trial team
after discharge of the patient. Additionally, the conduct of an in-
dependent blind review of medical records associated with positive
and negative HAIs offered some assurance regarding the consis-
tency with which the primary outcome was assessed. For the sake
Table 3
Infection type and pathogen associated with HAI
Type of
infection Intervention rooms (copper) Control rooms
BSI 15 infections
Fungal infections
Candida albicans: 1
Gram-positive infections: 9
Staphylococcus aureus: 1
Staphylococcus epidermidis: 3
Staphylococcus haemolyticus: 2
Staphylococcus hominis: 2
Staphylococcus pyogenes: 1
Gram-negative infections: 4
Klebsiella pneumoniae: 3
Enterobacter cloacae: 1
11 infections
Fungal infections
Gram-positive infections: 5
S aureus: 2
S epidermidis: 3
Gram-negative infections: 6
K oxytoca: 2
Klebsiella pneumoniae: 3
Haemophilus inﬂuenzae
type B: 1
PNEU 7 infections
Culture negative: 3
Fungal infections
Candida parapsilosis: 1
Gram-positive infections: 1
Streptococcus pneumoniae
Gram-negative infections: 2
Pseudomonas aeruginosa: n = 1
Haemophilus inﬂuenzae type B: 1
4 infections
Culture negative: 0
Fungal infections: 0
Gram-positive infections: 1
S pneumoniae
Gram-negative infections: 3
P aeruginosa: 1
H inﬂuenzae type B: 2
UTI 9 infections
Fungal infections: 0
Gram-positive infections: 2
Enterococcus faecalis: 2
Gram-negative infections: 7
Escherichia coli: 5
Klebsiella oxytoca: 1
Pseudomonas aeruginosa: 1
16 infections
Fungal infections: 1
C albicans: 1
Gram-positive infections: 3
E faecalis: 3
Gram-negative infections: 13
E coli: 8
K pneumoniae: 2
Proteus mirabilis: 1
E cloacae: 1
SSI 1 infection
Fungal infections: 0
Gram-positive infections: 0
Gram-negative infections: 1
Escherichia coli
2 infections
Fungal infections: 1
Candida lusitaniae
Gram-positive infections: 1
S aureus: 1
BSI, bloodstream infection; HAI, health care–associated infection; PNEU, pneumo-
nia; SSI, surgical site infection; UTI, urinary tract infection.
e137B. von Dessauer et al. / American Journal of Infection Control 44 (2016) e133-e139
of clariﬁcation, a κ test for agreement of 0.41 must be interpreted
as a 41% agreement on top of what could be expected if the rating
was performed at random.20
Our results are generalizable to PICUs that present with com-
parable populations in terms of demography, HAI incidence rates,
and type of infection reported. For example, the baseline HAI rate
in our setting seemed to be a low rate (crude frequency rate of
13%) when compared with reported rates in PICUs of comparable
countries, such as Brazil and Peru, where the crude HAI rates re-
ported are 18% and 20%, respectively.21,22 This low HAI acquisition
rate may have also contributed to a lower than expected copper
effect.
In thinking about the value proposition that the addition of a
limited number of copper components offers to a comprehensive
systems-based approach to control HAIs, a consideration of the
data from the cost-beneﬁt model developed by York Health Eco-
nomic Consortium is warranted. Here the authors developed a
cost-beneﬁt model that was populated with established datasets
relevant to the proﬁles for UK hospitals. The model assumed a
copper size effect of 20% reduction of HAI rates. The model
yielded a return of investment of 1 month and a cost per infection
averted of £120.23 Therefore, a target difference of ≥20% reduction
of HAIs seems a reasonable size effect from an economic and
policy decision perspective, conﬁrming the potential value that
our results and copper components offer to a systems-based
approach for controlling HAIs.
Considering the methodologic diﬃculties faced when evaluat-
ing this kind of environmental interventions, we concur with Stone
et al24 to give more priority to time series experimental designs
because they are best suited to detect temporal and nonindependent
events as the ones studied in this clinical trial.
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